A Phase III, randomized double-blind comparative study of KRP-AM1977Y for patients with community acquired pneumonia
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Lascufloxacin (Primary) ; Levofloxacin
- Indications Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 01 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2016 Status changed from not yet recruiting to recruiting.
- 05 Jul 2016 New trial record